Supplementary Material for: Dipeptidyl Peptidase-4 Inhibitors in Chronic Kidney Disease: A Systematic Review of Randomized Clinical Trials

Background: Chronic kidney disease (CKD) is common in patients with type 2 diabetes mellitus (T2DM) and limits therapeutic options. Dipeptidyl peptidase-4 (DPP-4) inhibitors represent a novel class of oral glucose-lowering agents and are known to be safe and effective in the general population. Meth...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	Walker, S.R., Komenda, P., Khojah, S., Al-Tuwaijri, W., MacDonald, K., Hiebert, B., Tangri, N., Nadurak S.W.D., Ferguson, T.W., Rigatto, C.
Format:	Dataset
Sprache:	eng
Schlagworte:	Medicine
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!